From €4292EUR$4,900USD£3,725GBP
- Report
- February 2025
- 100 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- November 2025
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- July 2025
Global
From €4292EUR$4,900USD£3,725GBP
- Report
- February 2026
- 282 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 386 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 575 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 195 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 484 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 373 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- August 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 140 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 89 Pages
Middle East
From €4248EUR$4,850USD£3,687GBP
- Report
- March 2022
- 273 Pages
Global
From €2299EUR$2,625USD£1,995GBP
€4598EUR$5,250USD£3,991GBP

The Cancer Management market within the context of Oncology is a rapidly growing sector of the healthcare industry. It encompasses a wide range of services, products, and technologies that are used to diagnose, treat, and manage cancer. This includes treatments such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy, as well as diagnostic tests, imaging, and other supportive care services. The market also includes a variety of products and services related to cancer prevention, such as screening tests, lifestyle modifications, and genetic testing.
The Cancer Management market is driven by advances in technology, increasing prevalence of cancer, and the growing demand for personalized treatments. Additionally, the increasing availability of healthcare services and the rising awareness of cancer among the general population are also contributing to the growth of the market.
Some of the major companies in the Cancer Management market include Roche, Novartis, Merck, Pfizer, Bristol-Myers Squibb, AstraZeneca, and Johnson & Johnson. Show Less Read more